Dalagon, Deborah N.

HRN: 13-28-20  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2024
CEFTRIAXONE 1G (VIAL)
02/17/2024
02/29/2024
IVT
2g
OD
T/c Complicated UTI, T2DM Poorly Controlled With Complications
Waiting Final Action 
02/18/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/18/2024
02/25/2024
IV
2.25g
Q6h
T/c Sepsis
Waiting Final Action 
02/20/2024
CEFTAZIDIME 1GM (VIAL)
02/20/2024
02/26/2024
IV
1 Gram
Q 12 Hrs
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: